Cargando…
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
In this study, the therapeutic efficacy of quercetin in combination with remdesivir and favipiravir, were evaluated in severe hospitalized COVID-19 patients. Our main objective was to assess the ability of quercetin for preventing the progression of the disease into critical phase, and reducing the...
Autores principales: | Shohan, Mojtaba, Nashibi, Roohangiz, Mahmoudian-Sani, Mohammad-Reza, Abolnezhadian, Farhad, Ghafourian, Mehri, Alavi, Seyed Mohammad, Sharhani, Asaad, Khodadadi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638148/ https://www.ncbi.nlm.nih.gov/pubmed/34863994 http://dx.doi.org/10.1016/j.ejphar.2021.174615 |
Ejemplares similares
-
Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2022) -
Prevalence and Mortality of Influenza A (H1N1) Virus Among Patients With Acute Respiratory Infection in Southwest Iran
por: Alavi, Seyed Mohammad, et al.
Publicado: (2014) -
Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
por: Salmanzadeh, Shokrollah, et al.
Publicado: (2020) -
Anti-inflammatory potential of Quercetin in COVID-19 treatment
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2021) -
Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff
por: Nashibi, Roohangiz, et al.
Publicado: (2015)